Home
Nation
States
International
Politics
Opinion
Economy
Sports
Entertainment
Trending:
August 7, 2024, 10:58 AM - 2 min read
Originally developed as a treatment for type 2 diabetes, so-called “skinny jabs” containing the appetite-suppressant semaglutide are a relatively recent innovation.